LivaNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.

About LIVN

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). 

CEO
Vladimir A. Makatsaria
CEOVladimir A. Makatsaria
Employees
2,900
Employees2,900
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2015
Founded2015
Employees
2,900
Employees2,900

LIVN Key Statistics

Market cap
3.32B
Market cap3.32B
Price-Earnings ratio
-15.17
Price-Earnings ratio-15.17
Dividend yield
Dividend yield
Average volume
520.08K
Average volume520.08K
High today
$61.44
High today$61.44
Low today
$60.40
Low today$60.40
Open price
$61.11
Open price$61.11
Volume
686.11K
Volume686.11K
52 Week high
$65.57
52 Week high$65.57
52 Week low
$32.48
52 Week low$32.48

Stock Snapshot

With a market cap of 3.32B, LivaNova(LIVN) trades at $60.86. The stock has a price-to-earnings ratio of -15.17.

During the trading session on 2026-01-14, LivaNova(LIVN) shares reached a daily high of $61.44 and a low of $60.40. At a current price of $60.86, the stock is +0.8% higher than the low and still -0.9% under the high.

Trading activity shows a volume of 686.11K, compared to an average daily volume of 520.08K.

The stock's 52-week range extends from a low of $32.48 to a high of $65.57.

The stock's 52-week range extends from a low of $32.48 to a high of $65.57.

LIVN News

TipRanks 12h
LivaNova Announces Chief Legal Officer Resignation and Succession

Claim 70% Off TipRanks Premium LivaNova ( (LIVN) ) has issued an announcement. On January 12, 2026, LivaNova PLC announced that Michael Hutchinson has resigne...

Simply Wall St 4d
LivaNova Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies Portfolio - What's Changed

In early January 2026, LivaNova attracted a wave of favorable analyst attention, with multiple firms reiterating positive ratings and raising their outlook on t...

LivaNova Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies Portfolio - What's Changed
Simply Wall St 5d
Assessing LivaNova Valuation After Recent Share Price Momentum And Perceived Intrinsic Discount

LivaNova (LIVN) has drawn fresh attention after recent trading, with the stock last closing at $64.95. Investors are weighing this move against the company’s cu...

Assessing LivaNova Valuation After Recent Share Price Momentum And Perceived Intrinsic Discount

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

More LIVN News

TipRanks 6d
LivaNova price target raised to $67 from $58 at Barclays

Barclays raised the firm’s price target on LivaNova (LIVN) to $67 from $58 and keeps an Equal Weight rating on the shares. The firm cites an increased target mu...

People also own

Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .